Skip to main content
. 2016 Nov 24;8(6):10620–10627. doi: 10.18632/oncotarget.13538

Table 2. Comparisons of AUC for the discrimination between breast cancer and benign tissue by BPER.

Menopause status Phase AUC 95%CI P Cutoffpoint Sensitivity Specificity
Cancer vs normal Premenopausal Early 0.665 0.555-0.775 0.006
Mid 0.704 0.599-0.808 0.001 40.3% 65.96% 68.09%
Late 0.687 0.580-0.794 0.002
Postmenopausal Early 0.668 0.567-0.769 0.003 10.05% 87.04% 40.74%
Mid 0.647 0.543-0.751 0.008
Late 0.631 0.524-0.738 0.019
Cancer vs benign Premenopausal Early 0.554 0.437-0.672 0.364
Mid 0.622 0.509-0.736 0.041 51.4% 46.81% 78.72%
Late 0.581 0.465-0.698 0.173
Postmenopausal Early 0.633 0.529-0.738 0.017 13.3% 72.22% 46.3%
Mid 0.565 0.456-0.674 0.244
Late 0.545 0.436-0.654 0.421

AUC, area under the curve; BPER, background parenchymal enhancement rate; CI, confidence interval